PRELUDE THERAPEUTICS INC (PRLD) Stock Balance Sheet
USA - NASDAQ:PRLD - US74065P1012 - Common Stock
1.52 USD
+0.01 (+0.66%)
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 12.47M | 25.29M | 30.60M | 31.80M | 218.30M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 121.14M | 207.64M | 171.10M | 259.40M | null | |||
| Receivables | null | null | null | null | null | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 2.28M | 2.65M | 2.70M | 3.90M | 2.50M | |||
| Total Current Assets | 135.90M | 235.59M | 204.40M | 295.10M | 220.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 35.47M | 37.74M | 6.70M | 5.60M | 2.50M | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | 4.15M | 4.34M | 9.40M | 4.30M | 300.00K | |||
| Total Non-Current Assets | 39.62M | 42.08M | 16.10M | 10.00M | 2.80M | |||
| TOTAL ASSETS | 175.51M | 277.67M | 220.50M | 305.10M | 223.60M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | 208.00K | null | null | null | 0 | |||
| Accrued Expenses | 16.93M | 16.30M | 14.40M | 11.30M | 7.00M | |||
| Accounts Payable | 7.73M | 4.58M | 6.80M | 7.80M | 3.90M | |||
| Other Current Liabilities | 771.00K | 945.00K | 500.00K | 100.00K | 400.00K | |||
| Total Current Liabilities | 25.64M | 21.83M | 21.70M | 19.20M | 11.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 18.41M | 18.75M | 3.40M | 0 | 0 | |||
| Total Non-Current Liabilities | 18.41M | 18.75M | 3.40M | 0 | 0 | |||
| TOTAL LIABILITIES | 44.06M | 40.58M | 25.10M | 19.20M | 11.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -583.56M | -456.39M | -334.60M | -219.10M | -107.40M | |||
| Additional Paid In Capital | 714.98M | 693.25M | 531.70M | 505.70M | 319.60M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 5.00K | 5.00K | 0 | 0 | 0 | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | 35.00K | 223.00K | -1.70M | -700.00K | null | |||
| Shares Outstanding | 55.15M | 54.91M | 47.90M | 47.60M | 43.70M | |||
| Tangible Book Value per Share | 2.3837 | 4.3175 | 4.0793 | 6.0063 | 4.8558 | |||
| Total Shareholders' Equity | 131.46M | 237.09M | 195.40M | 285.90M | 212.20M | |||
| TOTAL LIABILITIES AND EQUITY | 175.51M | 277.67M | 220.50M | 305.10M | 223.60M | |||
| Statistics | ||||||||
| Current Ratio | 5.30 | 10.79 | 9.42 | 15.37 | 19.37 | |||
| Return On Assets (ROA) | -72.46% | -43.88% | -52.35% | -36.61% | -25.46% | |||
| Return On Equity (ROE) | -96.74% | -51.39% | -59.08% | -39.07% | -26.83% | |||
All data in USD , ROIC based on taxRate of 0.21